Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas Cancer
Overview
Oncology
Affiliations
Successful surgical resection offers the only chance for cure in patients with pancreatic cancer. However, pancreatic resection is feasible in less than 20% of the patients. In this review, the current state of surgical management of pancreatic cancer is discussed. The definition of resectability based on cross-sectional imaging and the technical aspects of surgery, including vascular resection and/or reconstruction, management of aberrant vascular anatomy and extent of lymphadenectomy, are appraised. Furthermore, common pancreatic resection-specific postoperative complications and their management are reviewed.
Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma.
Jain A, Maxwell J, Katz M, Snyder R Cancers (Basel). 2023; 15(16).
PMID: 37627202 PMC: 10453019. DOI: 10.3390/cancers15164174.
Prognosticating Outcome in Pancreatic Head Cancer With the use of a Machine Learning Algorithm.
Baig Z, Abu-Omar N, Khan R, Verdiales C, Frehlick R, Shaw J Technol Cancer Res Treat. 2021; 20:15330338211050767.
PMID: 34738844 PMC: 8573477. DOI: 10.1177/15330338211050767.
Surgical Treatment of Pancreatic Ductal Adenocarcinoma.
Wei K, Hackert T Cancers (Basel). 2021; 13(8).
PMID: 33923884 PMC: 8074119. DOI: 10.3390/cancers13081971.
Advances in surgery for pancreatic cancer.
Acher A, Bleicher J, Cannon A, Scaife C J Gastrointest Oncol. 2019; 9(6):1037-1043.
PMID: 30603122 PMC: 6286930. DOI: 10.21037/jgo.2018.05.05.